|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-5-30
|
|
pubmed:abstractText |
The objective of the study was to evaluate the efficacy and toxicity of Temozolomide (TMZ) administered for 5 consecutive days in three daily dosing in children with recurrent or refractory high-grade glioma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0167-594X
|
|
pubmed:author |
pubmed-author:AbateM EME,
pubmed-author:AttinàGG,
pubmed-author:CaldarelliMM,
pubmed-author:CefaloGG,
pubmed-author:ClericiGG,
pubmed-author:ColosimoCC,
pubmed-author:Di RoccoCC,
pubmed-author:GarréM LML,
pubmed-author:LazzareschiII,
pubmed-author:MadonEE,
pubmed-author:MassiminoMM,
pubmed-author:MauriziPP,
pubmed-author:MazzarellaGG,
pubmed-author:RiccardiRR,
pubmed-author:RidolaVV,
pubmed-author:RuggieroAA,
pubmed-author:SandriAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
89-94
|
|
pubmed:meshHeading |
pubmed-meshheading:16292488-Adolescent,
pubmed-meshheading:16292488-Antineoplastic Agents, Alkylating,
pubmed-meshheading:16292488-Bone Marrow,
pubmed-meshheading:16292488-Brain Neoplasms,
pubmed-meshheading:16292488-Child,
pubmed-meshheading:16292488-Child, Preschool,
pubmed-meshheading:16292488-Dacarbazine,
pubmed-meshheading:16292488-Disease-Free Survival,
pubmed-meshheading:16292488-Drug Administration Schedule,
pubmed-meshheading:16292488-Female,
pubmed-meshheading:16292488-Glioma,
pubmed-meshheading:16292488-Humans,
pubmed-meshheading:16292488-Male,
pubmed-meshheading:16292488-Neoplasm Recurrence, Local,
pubmed-meshheading:16292488-Neutropenia,
pubmed-meshheading:16292488-Thrombocytopenia,
pubmed-meshheading:16292488-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Phase II trial of temozolomide in children with recurrent high-grade glioma.
|
|
pubmed:affiliation |
Dipartimento di Scienze Pediatriche, Medico-Chirurgiche e di Neuroscienze dello Sviluppo, Università Cattolica, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
